Abstract
Allogeneic hematopoietic stem cell transplantation (allo-HSCT) can cure leukaemia. However, long term complications of post transplantation interfere with the patients' full recovery. The objective of this review was to identify the various long term complications and to assess their individual prevalences. Electronic databases including PubMed, Google Scholar and Cochrane were searched for years 2004-2017. The keywords used were leukaemia, allogenic stem cell transplantation, prevalence, side effects, long term, delayed, adverse effects, complications and outcome. A total of ten articles were included for analysis. There were 5 prospective studies, 3 retrospective studies and 2 cross sectional studies. A total of 40,069 patients, (20,189 males and 17,191 females) participated in these 10 studies. The gender of 2689 patients were not disclosed. Most common late complications and prevalence were chronic graft versus host disease (43% at 5 years post HSCT), secondary tumor (21% at 20 years post HSCT), hypothyroidism (11% at 15 years), bronchiolitis obliterans (9.7% at 122 days), cardiovascular disease (7.5% at 15 years) and avascular necrosis (5.4% at 10 years). The prevalence of azoospermia was 71.1% and depression, 18%. For the...Continue Reading
References
Nov 1, 1984·Transplantation·B LönnqvistG Lundgren
Oct 3, 1998·Bone Marrow Transplantation·A WiesmannH Einsele
Nov 30, 1999·Annals of Internal Medicine·H J KolbH G Prentice
Mar 10, 2001·Stem Cells·C Cutler, J H Antin
Jul 5, 2002·The New England Journal of Medicine·Joseph H Antin
Mar 29, 2003·Blood·Marco MielcarekRainer Storb
May 15, 2004·British Journal of Haematology·Meghan A Higman, Georgia B Vogelsang
May 15, 2004·British Journal of Haematology·Tetsuya E TanimotoMine Harada
Apr 27, 2005·Bone Marrow Transplantation·S YoshiharaS Mineishi
Jul 2, 2005·Leukemia·M RobinG Socié
Jul 9, 2005·Chest·Linus H Santo TomasMary M Horowitz
Mar 18, 2006·Blood·Alicia RovóChristian De Geyter
Oct 4, 2007·Blood·Debra L FriedmanUNKNOWN EBMT-Late Effect Working Party
Jun 17, 2008·Haematologica·André TichelliUNKNOWN EBMT Late Effects Working Party
Jul 25, 2008·Blood·Joel S Bennett
Oct 31, 2008·Blood·J Douglas RizzoH Joachim Deeg
Dec 24, 2008·Blood·Yoshiko AtsutaUNKNOWN Japan Cord Blood Bank Network
Jun 19, 2009·Cancer·Stephanie CampbellSmita Bhatia
Sep 15, 2009·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Ian Nivison-SmithKenneth F Bradstock
Nov 10, 2009·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Jason W ChienSteven Z Pavletic
Jan 13, 2010·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Paul J MartinBarry E Storer
May 5, 2010·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Boglarka GyurkoczaBrenda M Sandmaier
Dec 4, 2010·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Brandon K C AuJason W Chien
Jan 18, 2011·Hematology·Mohamad Mohty, Jane F Apperley
Aug 2, 2011·Expert Review of Hematology·Smita Bhatia
Jun 9, 2015·The Journal of Clinical Investigation·Marie BleakleyWarren D Shlomchik
Feb 11, 2016·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Claire M VajdicUNKNOWN CAST study investigators
Mar 4, 2017·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Fotios V MichelisHans A Messner
Jan 31, 2018·PloS One·Dangui ChenBing Chen
May 10, 2018·Blood Advances·Anita J KumarAlison W Loren